These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32928251)

  • 1. Tie2-mediated vascular remodeling by ferritin-based protein C nanoparticles confers antitumor and anti-metastatic activities.
    Choi YS; Jang H; Gupta B; Jeong JH; Ge Y; Yong CS; Kim JO; Bae JS; Song IS; Kim IS; Lee YM
    J Hematol Oncol; 2020 Sep; 13(1):123. PubMed ID: 32928251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
    Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
    Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment.
    Park JS; Kim IK; Han S; Park I; Kim C; Bae J; Oh SJ; Lee S; Kim JH; Woo DC; He Y; Augustin HG; Kim I; Lee D; Koh GY
    Cancer Cell; 2016 Dec; 30(6):953-967. PubMed ID: 27960088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296.
    Langenkamp E; Zwiers PJ; Moorlag HE; Leenders WP; St Croix B; Molema G
    Anticancer Drugs; 2012 Feb; 23(2):161-72. PubMed ID: 22075979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment
    Park S; Oh JH; Park DJ; Zhang H; Noh M; Kim Y; Kim YS; Kim H; Kim YM; Ha SJ; Kwon YG
    Front Immunol; 2020; 11():620166. PubMed ID: 33584714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
    Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
    J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
    Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
    Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
    Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
    J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.
    Goel S; Gupta N; Walcott BP; Snuderl M; Kesler CT; Kirkpatrick ND; Heishi T; Huang Y; Martin JD; Ager E; Samuel R; Wang S; Yazbek J; Vakoc BJ; Peterson RT; Padera TP; Duda DG; Fukumura D; Jain RK
    J Natl Cancer Inst; 2013 Aug; 105(16):1188-201. PubMed ID: 23899555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
    Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
    Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
    Touil YS; Seguin J; Scherman D; Chabot GG
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):445-55. PubMed ID: 21069336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with xenogeneic tumor endothelial proteins isolated in situ inhibits tumor angiogenesis and spontaneous metastasis.
    Zhang W; Liu JN; Tan XY
    Int J Cancer; 2009 Jul; 125(1):124-32. PubMed ID: 19350628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
    Stoeltzing O; Ahmad SA; Liu W; McCarty MF; Wey JS; Parikh AA; Fan F; Reinmuth N; Kawaguchi M; Bucana CD; Ellis LM
    Cancer Res; 2003 Jun; 63(12):3370-7. PubMed ID: 12810673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
    Nakagawa K; Sasaki Y; Kato S; Kubodera N; Okano T
    Carcinogenesis; 2005 Jun; 26(6):1044-54. PubMed ID: 15718253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin.
    Shen Y; Li S; Wang X; Wang M; Tian Q; Yang J; Wang J; Wang B; Liu P; Yang J
    J Exp Clin Cancer Res; 2019 Oct; 38(1):427. PubMed ID: 31656203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism.
    Bix G; Castello R; Burrows M; Zoeller JJ; Weech M; Iozzo RA; Cardi C; Thakur ML; Barker CA; Camphausen K; Iozzo RV
    J Natl Cancer Inst; 2006 Nov; 98(22):1634-46. PubMed ID: 17105986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.
    Holopainen T; Saharinen P; D'Amico G; Lampinen A; Eklund L; Sormunen R; Anisimov A; Zarkada G; Lohela M; Heloterä H; Tammela T; Benjamin LE; Ylä-Herttuala S; Leow CC; Koh GY; Alitalo K
    J Natl Cancer Inst; 2012 Mar; 104(6):461-75. PubMed ID: 22343031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage.
    Miljkovic-Licina M; Hammel P; Garrido-Urbani S; Lee BP; Meguenani M; Chaabane C; Bochaton-Piallat ML; Imhof BA
    Mol Cancer Ther; 2012 Dec; 11(12):2588-99. PubMed ID: 23002094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.